Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 01 04:00PM ET
118.60
Dollar change
+5.23
Percentage change
4.61
%
IndexS&P 500 P/E36.07 EPS (ttm)3.29 Insider Own0.66% Shs Outstand1.73B Perf Week3.83%
Market Cap215.20B Forward P/E22.98 EPS next Y5.16 Insider Trans-2.81% Shs Float1.72B Perf Month5.68%
Income5.75B PEG4.17 EPS next Q1.34 Inst Own77.19% Short Float0.81% Perf Quarter9.18%
Sales41.22B P/S5.22 EPS this Y5.29% Inst Trans0.66% Short Ratio2.78 Perf Half Y11.99%
Book/sh22.94 P/B5.17 EPS next Y10.39% ROA7.85% Short Interest13.98M Perf Year24.83%
Cash/sh4.29 P/C27.63 EPS next 5Y8.65% ROE14.87% 52W Range92.43 - 121.64 Perf YTD7.75%
Dividend Est.2.21 (1.87%) P/FCF33.18 EPS past 5Y19.65% ROI10.92% 52W High-2.50% Beta0.72
Dividend TTM2.20 (1.85%) Quick Ratio1.14 Sales past 5Y6.10% Gross Margin50.98% 52W Low28.31% ATR (14)2.15
Dividend Ex-DateOct 15, 2024 Current Ratio1.60 EPS Y/Y TTM7.89% Oper. Margin16.50% RSI (14)59.91 Volatility1.56% 1.57%
Employees114000 Debt/Eq0.38 Sales Y/Y TTM3.15% Profit Margin13.94% Recom1.76 Target Price131.09
Option/ShortYes / Yes LT Debt/Eq0.32 EPS Q/Q14.65% Payout63.81% Rel Volume1.99 Prev Close113.37
Sales Surprise0.80% EPS Surprise0.65% Sales Q/Q4.85% EarningsOct 16 BMO Avg Volume5.04M Price118.60
SMA202.29% SMA503.20% SMA2007.27% Trades Volume10,001,551 Change4.61%
Date Action Analyst Rating Change Price Target Change
Oct-08-24Initiated Oppenheimer Outperform $130
Sep-19-24Initiated Piper Sandler Overweight $131
Jul-30-24Downgrade Edward Jones Buy → Hold
May-30-24Initiated Goldman Buy $121
Jul-21-23Upgrade Wolfe Research Underperform → Peer Perform
May-30-23Downgrade Morgan Stanley Overweight → Equal-Weight $112
Apr-20-23Reiterated Wolfe Research Underperform $107 → $103
Apr-20-23Reiterated UBS Buy $117 → $130
Apr-20-23Reiterated Raymond James Outperform $116 → $123
Apr-20-23Reiterated JP Morgan Overweight $118 → $122
Nov-01-24 04:09PM
03:55PM
11:11AM
10:24AM
09:44AM
07:16AM Loading…
07:16AM
06:04AM
06:04AM
04:59AM
01:11AM
Oct-30-24 09:50AM
08:00AM
Oct-26-24 07:30AM
Oct-25-24 09:10AM
Oct-24-24 09:00AM
01:03PM Loading…
Oct-23-24 01:03PM
09:00AM
Oct-19-24 09:57AM
Oct-18-24 03:26PM
09:30AM
05:10AM
Oct-17-24 02:55PM
02:42PM
11:17AM
07:35AM
07:30AM
03:01AM
01:21AM
Oct-16-24 06:41PM
04:14PM
03:47PM Loading…
03:47PM
02:17PM
01:45PM
12:15PM
12:14PM
12:10PM
10:49AM
10:21AM
09:30AM
09:08AM
08:40AM
08:00AM
07:58AM
07:47AM
07:38AM
07:37AM
07:30AM
Oct-15-24 11:48AM
08:46AM
Oct-13-24 06:00AM
Oct-11-24 12:38PM
09:15AM
07:14AM
Oct-10-24 09:00AM
Oct-09-24 10:00AM
09:00AM
07:46AM
Oct-08-24 06:00PM
Oct-07-24 11:05AM
Oct-05-24 09:07AM
04:45AM
Oct-02-24 06:00PM
08:35AM
08:00AM
04:11AM
Oct-01-24 12:10PM
Sep-30-24 04:49AM
Sep-28-24 01:21PM
05:00AM
Sep-27-24 09:30AM
09:00AM
Sep-26-24 06:00PM
02:00PM
Sep-25-24 09:00AM
06:35AM
Sep-20-24 05:50PM
Sep-19-24 12:59PM
09:01AM
04:49AM
04:44AM
04:39AM
04:35AM
04:30AM
04:07AM
04:03AM
03:59AM
03:55AM
03:46AM
Sep-18-24 08:00AM
Sep-16-24 06:58PM
06:00PM
09:00AM
05:12AM
Sep-13-24 09:00AM
Sep-11-24 06:59AM
Sep-10-24 05:50PM
Sep-05-24 04:08PM
02:45PM
09:30AM
09:29AM
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTOct 21 '24Option Exercise47.00157,4217,398,787342,227Oct 23 05:10 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTOct 21 '24Sale117.04157,42118,424,298184,806Oct 23 05:10 PM
ALLEN HUBERT LOfficerOct 21 '24Proposed Sale118.89157,42118,715,783Oct 21 04:08 PM
Ford Robert BCHAIRMAN AND CEOSep 12 '24Option Exercise47.19141,6796,685,975361,738Sep 13 05:24 PM
Ford Robert BCHAIRMAN AND CEOSep 12 '24Sale116.41141,67916,493,218220,059Sep 13 05:24 PM
Robert B. FordOfficerSep 12 '24Proposed Sale116.41141,67916,492,852Sep 12 06:20 PM
MCCOY JOHN A. JR.VICE PRESIDENTSep 04 '24Sale114.83273,10018,681Sep 04 07:52 PM
Funck, Jr. Robert E.OfficerSep 04 '24Proposed Sale115.0030,0003,450,000Sep 04 04:04 PM
Funck, Jr. Robert E.EXECUTIVE VICE PRESIDENTMay 10 '24Option Exercise47.0010,097474,559221,438May 14 05:35 PM
Funck, Jr. Robert E.EXECUTIVE VICE PRESIDENTMay 10 '24Sale104.5710,0971,055,819211,341May 14 05:35 PM
Earnhardt Lisa DEXECUTIVE VICE PRESIDENTMay 07 '24Sale106.2522,8522,428,11961,462May 08 05:00 PM
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTMar 01 '24Sale118.50963114,116125,697Mar 04 07:18 PM
Morrone Louis H.EXECUTIVE VICE PRESIDENTMar 01 '24Sale118.5080194,91862,968Mar 04 07:14 PM
Moreland Mary KEXECUTIVE VICE PRESIDENTMar 01 '24Sale118.5067680,10691,260Mar 04 07:09 PM
MCCOY JOHN A. JR.VICE PRESIDENTMar 01 '24Sale118.5047255,93218,760Mar 04 07:05 PM
Earnhardt Lisa DEXECUTIVE VICE PRESIDENTMar 01 '24Sale118.5069482,23984,314Mar 04 06:50 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTMar 01 '24Sale118.50853101,080184,806Mar 04 06:39 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTFeb 23 '24Option Exercise59.9412,500749,25091,204Feb 27 06:13 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTFeb 23 '24Sale120.0012,5001,500,00078,704Feb 27 06:13 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTJan 29 '24Option Exercise50.8042,5002,158,95090,027Jan 31 05:30 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTJan 29 '24Sale112.5042,5004,781,25065,027Jan 31 05:30 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTDec 14 '23Option Exercise44.4015,000666,00080,027Dec 18 05:36 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTDec 14 '23Sale108.0015,0001,620,00065,027Dec 18 05:36 PM